Fate Therapeutics, Inc. Share Price
NASDAQ: FATEHealthcare
Live Fate Therapeutics, Inc. Share Price Chart
O H L
Fate Therapeutics, Inc. Performance Overview
Days Range
▼
$2.52Low
$2.59High
Markets Today
| Previous Close | $2.52 |
|---|---|
| Open | $2.59 |
| Volume | 257,495 |
| Day's Range | $2.52 - $2.59 |
| 52W Range | $0.94 - $3.23 |
| Market Cap | $292.36 M |
Historical Performance
| 1M Returns | -1.56 |
|---|---|
| 3M Returns | +20.57 |
| 6M Returns | +137.74 |
| 1Y Returns | +152.00 |
| 5Y Returns | -96.48 |
| 10Y Returns | -16.00 |
Fate Therapeutics, Inc. Fundamentals
| Market Cap | $292.36 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $6.65 M |
| ROE TTM | -0.52 |
| EPS TTM | $-1.05 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.86 |
| EBITDA | $-134.80 M |
| Profit Margin | -2051.08 |
| Market Cap | $292.36 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $6.65 M |
| ROE TTM | -0.52 |
| EPS TTM | $-1.05 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.86 |
| EBITDA | $-134.80 M |
| Profit Margin | -2051.08 |
Fate Therapeutics, Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $1.63 M | $1.91 M | $1.74 M | $1.37 M | $1.30 M | $2.08 M |
| Gross Profit + | $1.63 M | $1.91 M | $1.74 M | $1.37 M | $1.30 M | $2.08 M |
| Operating Income | -$41.28 M | -$36.97 M | -$34.73 M | -$34.72 M | -$33.00 M | -$31.13 M |
| EBITDA | -$37.95 M | -$33.69 M | -$31.51 M | -$31.66 M | -$30.08 M | -$28.35 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $3.33 M | $3.28 M | $3.23 M | $3.06 M | $2.92 M | $2.78 M |
| Income Before Tax | -$37.62 M | -$34.07 M | -$32.25 M | -$32.37 M | -$31.21 M | -$30.16 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$37.62 M | -$34.07 M | -$32.25 M | -$32.37 M | -$31.21 M | -$30.16 M |
| Net Profit Margin | -2309.45% | -1786.58% | -1852.38% | -2364.79% | -2402.85% | -1448.56% |
Fate Therapeutics, Inc. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $115.00 K | $115.00 K | $115.00 K | $115.00 K | $116.00 K | $117.00 K |
| Reserve & Surplus | -$1.44 B | -$1.47 B | -$1.50 B | -$1.53 B | -$1.57 B | -$1.60 B |
| Non-Current Liabilities | $81.86 M | $81.28 M | $81.08 M | $75.40 M | $74.16 M | $73.13 M |
| Current Liabilities | $28.16 M | $28.67 M | $28.11 M | $36.07 M | $30.69 M | $32.59 M |
| Total Liabilities | $110.01 M | $109.95 M | $109.19 M | $111.47 M | $104.85 M | $105.72 M |
| Fixed Assets | $62.76 M | $61.10 M | $59.48 M | $56.92 M | $54.26 M | $51.55 M |
| Current Assets | $248.22 M | $230.40 M | $221.25 M | $208.70 M | $179.53 M | $157.95 M |
| Total Assets | $398.67 M | $371.63 M | $343.67 M | $318.94 M | $284.92 M | $260.10 M |
Fate Therapeutics, Inc. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$37.62 M | -$34.07 M | -$32.25 M | -$32.37 M | -$31.21 M | -$30.16 M |
| Operating Cash Flow | -$33.81 M | -$24.59 M | -$24.37 M | -$23.31 M | -$30.82 M | -$23.43 M |
| Investing Cash Flow | $42.67 M | $19.59 M | $21.27 M | $27.63 M | $23.59 M | $14.56 M |
| Financing Cash Flow | $0 | $1.32 M | $2.48 M | $1.69 M | $0 | $1.74 M |
| Change in Cash | $8.86 M | -$3.67 M | -$627.00 K | $6.01 M | -$7.24 M | -$7.14 M |
Fate Therapeutics, Inc. Return Calculator
The Fate Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$358
Invested Amount$10,000
Est. Returns$-9,642
About Fate Therapeutics, Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
Popular Stocks
FAQs
What is the share price of Fate Therapeutics, Inc. today?
Fate Therapeutics, Inc. (FATE) share price as of September 18, 2026 is $2.56. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Fate Therapeutics, Inc.?
Yes, Indian Investors can invest in the Fate Therapeutics, Inc. (FATE) Share by opening an international trading account with Angel One.
How can I purchase Fate Therapeutics, Inc. shares in India?
Purchasing Fate Therapeutics, Inc. (FATE) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Fate Therapeutics, Inc. (FATE) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Fate Therapeutics, Inc.?
Yes, you can purchase fractional shares of Fate Therapeutics, Inc. (FATE) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Fate Therapeutics, Inc.?
The market capitalization of Fate Therapeutics, Inc. on September 18, 2026, is $292.36 M.
In which sector Fate Therapeutics, Inc. belongs?
Fate Therapeutics, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Fate Therapeutics, Inc. stocks?
In order to invest in Fate Therapeutics, Inc. (FATE) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
